OpenAlex
PricingAboutJobs
Log inGet started
Work

Low dose mepolizumab as steroid sparing strategy in HES remission phase

HTML

Year: 2023
Type: article
Source: Journal of Allergy and Clinical Immunology
DOI: 10.1016/j.jaci.2022.12.351
Authors: Matteo Maule, Gianenrico Senna, Veronica Batani, Federica Maiolini, Simonetta Friso, Marco Caminati
Institutions: University of Verona, Azienda Ospedaliera Universitaria Integrata Verona
Language: English

Topic: Eosinophilic Disorders and Syndromes
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: mepolizumab, hypereosinophilic syndrome, steroid-sparing therapy, remission duration, anti-IL-4 receptor therapy, eosinophilic disorders
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4319082784
FWCI: 0.333
Cites:
Cited by: 2
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security